Latest / Medical Device Global Market Access
Japan PMDA SaMD Guidance 2026: AI/ML, Cybersecurity, and Classification Changes
On June 5, 2026, Japan's Pharmaceuticals and Medical Devices Agency (PMDA) issued a major update to its guidance for Software as a Medical Device (SaMD). This episode breaks down the three core changes: more stringent validation requirements for AI/ML algorithms, enhanced cybersecurity provisions aligned with global standards, and clearer classification rules for borderline products. We discuss the practical impact on technical documentation, submission timelines, and what steps manufacturers must take now to ensure compliance for market access in Japan. Key Questions: - What are the three…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.